NSCLC

You have access
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment
DANIEL KREJCI, PETR OPALKA, JANA KREJCI, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, MONIKA BRATOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, HELENA COUPKOVA, KAROLINA HURDALKOVA, MAGDA BARINOVA, LEONA KOUBKOVA, DANIEL DOLEZAL, MARTIN SAFANDA, MILOS PESEK and MARTIN SVATON

Anticancer Research May 2021, 41 (5) 2597-2603; DOI: https://doi.org/10.21873/anticanres.15039
You have access
Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy
MARTIN SVATON, JIRI BLAZEK, GABRIELA KRAKOROVA, MILOS PESEK, MARCELA BURESOVA, ZUZANA TEUFELOVA, JOSEF VODICKA, KAROLINA HURDALKOVA, MAGDA BARINOVA and ONDREJ TOPOLCAN

Anticancer Research April 2021, 41 (4) 2053-2058; DOI: https://doi.org/10.21873/anticanres.14974
You have access
Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study
MARTIN SVATON, MONIKA BRATOVA, ONDREJ FISCHER, JANA KREJCI, LEONA KOUBKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MILADA ZEMANOVA, HELENA COUPKOVA, BEDRICH PORZER, DANIEL DOLEZAL, TANA TUZOVA, KAROLINA HURDALKOVA, MAGDA BARINOVA and JANA SKRICKOVA

Anticancer Research April 2021, 41 (4) 2059-2065; DOI: https://doi.org/10.21873/anticanres.14975
You have access
Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer
MAX R. CLEVERS, ELISABETH A. KASTELIJN, BAS J.M. PETERS, HANS KELDER and FRANZ M.N.H. SCHRAMEL

Anticancer Research February 2021, 41 (2) 869-876; DOI: https://doi.org/10.21873/anticanres.14839
You have access
ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
KATHRIN FLESCHUTZ, LISA WALTER, RUMO LEISTNER and LUCIE HEINZERLING

Anticancer Research September 2020, 40 (9) 4937-4946; DOI: https://doi.org/10.21873/anticanres.14497
You have access
NCAPH Is Required for Proliferation, Migration and Invasion of Non-small-cell Lung Cancer Cells
BYEOL KIM, SEOK WON KIM, JI-YEON LIM and SEON-JOO PARK

Anticancer Research June 2020, 40 (6) 3239-3246; DOI: https://doi.org/10.21873/anticanres.14305
You have access
Overexpression of AGR2 Is Associated With Drug Resistance in Mutant Non-small Cell Lung Cancers
THI-THU-TRANG LUU, DUC-HIEP BACH, DONGHWA KIM, RUOCI HU, HYEN JOO PARK and SANG KOOK LEE

Anticancer Research April 2020, 40 (4) 1855-1866; DOI: https://doi.org/10.21873/anticanres.14139
You have access
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA and FARKHAD MANAPOV

Anticancer Research April 2020, 40 (4) 2319-2322; DOI: https://doi.org/10.21873/anticanres.14198
You have access
Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-small Lung Cancer Cells In Vitro and In Vivo
WOEI-HORNG CHAI, YI-RONG LI, SHENG-HAO LIN, YA-HUSAN CHAO, CHENG-HSIUNG CHEN, PO-CHIANG CHAN and CHING-HSIUNG LIN

Anticancer Research March 2020, 40 (3) 1405-1417; DOI: https://doi.org/10.21873/anticanres.14082
You have access
Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells
YICHAO LIU, RUDOLF M. HUBER, ROSEMARIE KIEFL, AMANDA TUFMAN and DIEGO KAUFFMANN-GUERRERO

Anticancer Research March 2020, 40 (3) 1451-1458; DOI: https://doi.org/10.21873/anticanres.14087

Main menu

User menu

Search

NSCLC

Pages